Seven Eight Capital »

Akero Therapeutics shares owned by Seven Eight Capital

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Seven Eight Capital from 13F filings

Historical chart of Seven Eight Capital investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Seven Eight Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Seven Eight Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.0M 40k 25.26

More positions owned by Seven Eight Capital

Paycom Software (PAYC)
Lyft Cl A Com (LYFT)
Spirit Aerosystems Hldgs Com Cl A (SPR)
Dick's Sporting Goods (DKS)
Core & Main Cl A (CNM)
Cardinal Health (CAH)
Equitable Holdings (EQH)
AmerisourceBergen (COR)
Best Buy (BBY)
Microsoft Corporation (MSFT)
Xcel Energy (XEL)
Palo Alto Networks (PANW)
Advanced Micro Devices (AMD)
Bunge Global Sa Com Shs (BG)
Mastercard Incorporated Cl A (MA)

View all positions for Seven Eight Capital

Top funds holding Akero Therapeutics

Henderson Group
General Atlantic
BlackRock
T. Rowe Price Associates
Vanguard Group
Wellington Management Company
Baker Bros. Advisors
Redmile Group
Boxer Capital
Alliancebernstein
Yiheng Capital
Geode Capital Management
Perceptive Advisors
Fred Alger Management
Rock Springs Capital Management

View all funds holding Akero Therapeutics